As previously mentioned, even if the exact mechanism is still unclear, CML cells may influence the expression of functional CXCL12 within the tumor microenvironment, thus favoring their egress from bone marrow to peripheral blood (67). Here, CXCL12 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.